LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases.Topline Phase 1 ...
By limiting joint damage, disability is reduced. The primary treatment for rheumatoid arthritis is medication to reduce immune system activity and inflammation. Five categories of drugs commonly used ...
In RA, the immune system attacks the lining of the joint (called the synovium) and causes inflammation, which leads to joint damage. Without treatment, this disease can lead to serious disability.
The word “arthritis” describes pain, stiffness, and swelling in the joints. It can be a bit of a nuisance or extremely difficult to live with. While arthritis is generally associated with age, it ...